Latest News
Postoperative CA19-9 Shows Prognostic Significance in Cholangiocarcinoma
Conditional Survival Rates Vary Following Intrahepatic Cholangiocarcinoma Surgery
Photodynamic Therapy Shows Potential for Cholangiocarcinoma Cell Inhibition
Predicting Prognosis in Hilar Cholangiocarcinoma With Lymph Node Staging Systems
Ivosidenib Appears Active in Patients With Cholangiocarcinoma
Clear Panel Design Criteria Can Ensure Accuracy of LCFAOD Diagnosis
New Model Has Potential for Early Detection of Cholangiocarcinoma
Minimally Invasive Right Hepatectomy Appears Promising for CCA
ADC Values Can Help Differentiate Intrahepatic Cholangiocarcinoma
Latest Clinical Trials
Features
Using Technology to Boost Ethnic, Geographic Diversity in Clinical Trials
Eliminating geographic and ethnic bias in clinical trials for rare diseases is the goal of Jeeva Informatics, says founder and CEO Harsha K. Rajasimha, PhD.
Cholangiocarcinoma Foundation Helps Improve Odds for Patients With Rare Bile Duct Cancer
Melinda Bachini, 52, never intended to be a patient advocate for a disease few people have ever heard of, let alone pronounce. But a Dec. 1, 2009, diagnosis of cholangiocarcinoma, also known as bile duct cancer, changed everything for the Billings, Montana, mother of 6. That day, the 41-year-old paramedic — who had been experiencing…
Israel Emerges as Global Powerhouse in Rare Disease Research
TEL AVIV, Israel — On the 6th floor of Schneider Children’s Hospital in the Tel Aviv suburb of Petah Tikva, 30 children with Alagille syndrome and 2 with lysosomal acid lipase deficiency (LAL-D) receive specialized treatment from a trio of pediatric hepatologists. Across town, at Sheba Medical Center’s Edmond and Lily Safra Children’s Hospital, pediatric…
NORD Recognizes Progress in Fight Against Rare Disease With 2021 Rare Impact Awards
Under COVID-19’s lingering shadow, the National Organization of Rare Disorders (NORD) has presented its 2021 Rare Impact Awards to 24 pharmaceutical firms, researchers, politicians, and nonprofit groups for their efforts over the past year on behalf of patients with such illnesses. The virtual ceremony was hosted by John Whyte, MD, MPH, chief medical officer at WebMD, with commentary…
FDA, CDC Urge COVID-19 Vaccines for Rare Disease Patients on NORD Webinar
As the super-contagious Delta variant of COVID-19 sweeps across the globe, driving up infection rates as well as deaths, top US health officials are urging everyone 12 and older — including the country’s 30 million or so rare disease patients — to get vaccinated quickly. Some 185 million people have been infected, and nearly 4…
Cholangiocarcinoma Clinical Insights
The Crucial Role of Correct, Timely Diagnosis in the Management of CCA
We explore the importance of correct and timely diagnosis of cholangiocarcinoma (CCA), which can be divided into iCCA, pCCA, and dCCA.
Guidelines for the Treatment of Resectable and Unresectable CCA
We examine and compare the latest guidelines on cholangiocarcinoma treatment, looking at both resectable and unresectable disease.
The Evolving Role of Endoscopy in the Management of Cholangiocarcinoma
We explore the work of Joe Geraghty from the Manchester Royal Infirmary in the UK, and others, to better understand the role of endoscopy in CCA management.
Tools for Earlier and More Accurate Diagnoses in Cholangiocarcinoma
We explore the currently available tools to help diagnose cholangiocarcinoma early, when the disease may still be resectable.
- Loading...
Loading...
Loading... 
Loading...